Hatch, Bennet Bill Sets Up New 'Dormant Drug' Class Eligible For 15 Years Exclusivity

Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO) have introduced legislation that picks up on a controversial House proposal to offer 15 years of data protection as an incentive for drug makers to develop therapies that treat one or more unmet medical needs. Brand drug makers back the idea and have urged its inclusion in the House Energy and Commerce Committee's upcoming 21st Century Cures bill, but some House Democrats, generic drug makers, AARP and pharmacy benefit managers charge the...